I 71 Pill - yellow round, 7mm
Pill with imprint I 71 is Yellow, Round and has been identified as Minocycline Hydrochloride 50 mg. It is supplied by Dr. Reddy’s Laboratories Inc.
Minocycline is used in the treatment of Bacterial Infection; Acne; Bullous Pemphigoid; Bartonellosis; Actinomycosis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for I 71


Minocycline Hydrochloride
- Imprint
- I 71
- Strength
- 50 mg
- Color
- Yellow
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC)
- 55111-0637
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
povidone,
FD&C Blue No. 2,
FD&C Yellow No. 5,
titanium dioxide,
hypromelloses,
polyethylene glycol,
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Related images for "I 71"
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (564)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Emrosi, Dynacin, Ximino, ... +3 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Emrosi, Minocin for Injection, Ximino, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.